Alerts will be sent to your verified email
Verify EmailEIKO
Eiko Lifesciences
|
Sunil Healthcare
|
Mysore Petro Chem
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-16.62 % | 1.91 % | 5.98 % |
5yr average Equity Multiplier
|
2.12 | 2.47 | 1.24 |
5yr Average Asset Turnover Ratio
|
0.56 | 0.77 | 0.1 |
5yr Avg Net Profit Margin
|
-3.7 % | 0.33 % | 59.44 % |
Price to Book
|
1.3 | 1.15 | 0.35 |
P/E
|
27.97 | 420.78 | 0.0 |
5yr Avg Cash Conversion Cycle
|
61.48 Days | 113.61 Days | 60.35 Days |
Inventory Days
|
214.38 Days | 64.09 Days | 5.18 Days |
Days Receivable
|
57.98 Days | 139.61 Days | 96.3 Days |
Days Payable
|
248.22 Days | 139.86 Days | 21.22 Days |
5yr Average Interest Coverage Ratio
|
-0.09 | 1.69 | 132.56 |
5yr Avg ROCE
|
-109.51 % | 9.44 % | 2.23 % |
5yr Avg Operating Profit Margin
|
-9.68 % | 5.47 % | -19.06 % |
5 yr average Debt to Equity
|
0.3 | 0.9 | 0.0 |
5yr CAGR Net Profit
|
60.2 % | -18.44 % | n/a |
5yr Average Return on Assets
|
-4.56 % | 1.18 % | 4.88 % |
Shareholdings
|
|||
Promoter Holding
|
36.74 % | 73.53 % | 72.99 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
23.26 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Eiko Lifesciences
|
Sunil Healthcare
|
Mysore Petro Chem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|